Sei Investments Co. Buys 57,948 Shares of InfuSystem Holdings, Inc. $INFU

Sei Investments Co. boosted its position in InfuSystem Holdings, Inc. (NYSE:INFU) by 123.8% during the 1st quarter, Holdings Channel.com reports. The firm owned 104,757 shares of the company’s stock after purchasing an additional 57,948 shares during the period. Sei Investments Co.’s holdings in InfuSystem were worth $967,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Hsbc Holdings PLC increased its position in InfuSystem by 5.7% in the first quarter. Hsbc Holdings PLC now owns 30,097 shares of the company’s stock worth $281,000 after buying an additional 1,619 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of InfuSystem by 0.8% during the 4th quarter. Geode Capital Management LLC now owns 218,123 shares of the company’s stock valued at $1,958,000 after buying an additional 1,831 shares during the last quarter. HighTower Advisors LLC lifted its position in shares of InfuSystem by 13.8% during the 4th quarter. HighTower Advisors LLC now owns 21,061 shares of the company’s stock valued at $189,000 after buying an additional 2,561 shares during the last quarter. Integrated Quantitative Investments LLC grew its stake in shares of InfuSystem by 6.9% during the 4th quarter. Integrated Quantitative Investments LLC now owns 41,484 shares of the company’s stock worth $372,000 after acquiring an additional 2,684 shares during the period. Finally, Dynamic Technology Lab Private Ltd grew its stake in shares of InfuSystem by 25.8% during the 4th quarter. Dynamic Technology Lab Private Ltd now owns 13,724 shares of the company’s stock worth $123,000 after acquiring an additional 2,811 shares during the period. 71.13% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, B. Riley Financial restated a “buy” rating and issued a $20.00 price objective (up from $12.00) on shares of InfuSystem in a research note on Wednesday, August 5th. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $16.67.

InfuSystem Stock Down 1.8%

INFU opened at $12.24 on Thursday. InfuSystem Holdings, Inc. has a 12 month low of $7.29 and a 12 month high of $12.97. The company has a market cap of $247.03 million, a PE ratio of 204.03 and a beta of 1.42. The company has a current ratio of 1.98, a quick ratio of 1.59 and a debt-to-equity ratio of 0.50. The company has a 50 day moving average of $9.73 and a 200 day moving average of $9.34.

InfuSystem declared that its Board of Directors has authorized a stock buyback plan on Tuesday, May 19th that authorizes the company to repurchase $20.00 million in shares. This repurchase authorization authorizes the company to repurchase up to 10.2% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company’s board believes its shares are undervalued.

InfuSystem Company Profile

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.